Alexander Opstad, who runs DNB Markets from Oslo, blames Europe’s revised rules for Markets in Financial Instruments (MiFID 2) for forcing many firms in his industry to cut back on the quality of research.
He also says clients have had enough of the new regime.
The “feedback from customers is unanimous,” Opstad said in an interview. “The quality of equity research has worsened since MiFID 2.” What’s more, “the breadth of research has shrunk,” he said.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for AMWatch has now started
With your free trial you get:
Full access to all locked articles on AMWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.